Health Products

Unicel Dxi 600 and 800 Access Immunoassay Br Monitors (2017-04-14)

· Published by Health Canada · Official notice

Details

Alert type: Medical Device Recall
Category: Medical Device
Issue: Medical Devices
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberBrand nameCompaniesModel or catalog number
All non-expired lots and future lotsB. Access Immunoassay System - Br Monitor (Ca 15-3) Assay
Manufacturer
Beckman Coulter Inc.
250 S. Kraemer Blvd.
Brea
92821
UNITED STATES
387620
All non-expired lots and future lotsC. Unicel Dxi 800 Access Immunoassay System - Br Monitor (Ca 15-3) Assay
Manufacturer
Beckman Coulter Inc.
250 S. Kraemer Blvd.
Brea
92821
UNITED STATES
387620
All non-expired lots and future lotsA. Unicel Dxi 600 Access Immunoassay System - Br Monitor (Ca 15-3) Assay
Manufacturer
Beckman Coulter Inc.
250 S. Kraemer Blvd.
Brea
92821
UNITED STATES
387620

Introduction

Affected Products

A. Unicel Dxi 600 Access Immunoassay System - Br Monitor (Ca 15-3) Assay
B. Access Immunoassay System - Br Monitor (Ca 15-3) Assay
C. Unicel Dxi 800 Access Immunoassay System - Br Monitor (Ca 15-3) Assay

Reason

Following biases observed in the results of the French national quality controls, Beckman Coulter has been informed that a study completed by the French competent authority Agence Nationale de Securite du Medicament et des Produits de Sante (ANSM) showed diagnosed cancer patients in non-remission of their metastatic disease, may have results below the upper reference limit (URL) of 31.3 u/ml as stated in the access BR monitor instructions for use (IFU).
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime